Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse AKR7A2 ELISA Kit (AC3552)
Cat.#: ASET-2141
Specifications
Description Mouse AKR7A2 ELISA Kit allows for the in vitro quantitative determination of mouse AKR7A2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1187 Rat VAP1 ELISA Kit (AC2598) Quantitative inquiry ASET-1534 Human Apolipoprotein E ELISA Kit (AC2945) Quantitative inquiry ASET-2306 Human Syndecan 4 ELISA Kit (AC3717) Quantitative inquiry ASET-2024 Mouse GALP ELISA Kit (AC3435) Quantitative inquiry ASET-2115 Mouse ERK2 ELISA Kit (AC3526) Quantitative inquiry ASET-2042 Human Ephrin A4 ELISA Kit (AC3453) Quantitative inquiry ASET-1200 Rat ERK2 ELISA Kit (AC2611) Quantitative inquiry ASET-1554 Human Neurofilament Heavy Polypeptide ELISA Kit (AC2965) Quantitative inquiry ASET-1210 Malondialdehyde ELISA Kit (AC2621) Quantitative inquiry ASET-2490 Human PSPN ELISA Kit (AC3901) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket